Shortages continue
The shortages for several oncological injectable products continue in Europe, US and several other countries. We do have close cooperation with several reputable Generic Manufacturers and deliver products with full documentation at reasonable prices. Last year we supplied bigger batches of Irinotecan, Paclitaxel, Docetaxel, Doxorubicin and Carboplatin to our customers and helped them to overcome product shortages or potential delays in clinical trials.